Equity Create Wealth
Sectoral Fund - Pharma & Health Care
Category Rank
Nippon India Pharma Fund - Growth Plan - Growth Option
Rating
Fund
Time to Invest
Nippon India Pharma Fund - Growth Plan - Growth Option
NAV
378.7992
(01/12/2023)
L 52Wk H
265.36
378.80
Login using to know what your Friends are Investing !

Nippon India Pharma Fund - Growth Plan - Growth Option

Equity
Sectoral Fund - Pharma & Health Care
Create Wealth
Rank Nippon India Pharma Fund - Growth Plan - Growth Option
Fund
NAV
378.7992
(01/12/2023)
Time to Invest
Nippon India Pharma Fund - Growth Plan - Growth Option
Rating
L 52Wk H
265.36
378.80

Asset Allocation for Nippon India Pharma Fund - Growth Plan - Growth Option Fund Growth

Top 10 Holdings of Nippon India Pharma Fund - Growth Plan - Growth Option Fund Growth

57.68 % of total assets
Sun Pharmaceutical Industries LimitedSun Pharmaceutical Industries Limited(12.89%)
Lupin LimitedLupin Limited(7.75%)
Cipla LimitedCipla Limited(6.50%)
Dr. Reddy's Laboratories LimitedDr. Reddy's Laboratories Limited(5.33%)
Apollo Hospitals Enterprise LimitedApollo Hospitals Enterprise Limited(4.47%)
MedPlus Health Services LimitedMedPlus Health Services Limited(4.40%)
Divi's Laboratories LimitedDivi's Laboratories Limited(4.29%)
Gland Pharma LimitedGland Pharma Limited(4.19%)
Triparty RepoTriparty Repo(4.04%)
Aurobindo Pharma LimitedAurobindo Pharma Limited(3.83%)

Detailed Portfolio of Nippon India Pharma Fund - Growth Plan - Growth Option Fund Growth

Portfolio Date -31 Oct 2023
Equity Holdings -30
Other Holdings -3
Holdings % Weight Value Sahi Hai/Nahi
Sun Pharmaceutical Industries Limited 12.89% 713.724 Cr
Lupin Limited 7.75% 429.112 Cr
Cipla Limited 6.50% 360.000 Cr
Dr. Reddy's Laboratories Limited 5.33% 295.231 Cr
Apollo Hospitals Enterprise Limited 4.47% 247.764 Cr
MedPlus Health Services Limited 4.40% 243.482 Cr
Divi's Laboratories Limited 4.29% 237.458 Cr
Gland Pharma Limited 4.19% 231.900 Cr
Aurobindo Pharma Limited 3.83% 212.375 Cr
JB Chemicals & Pharmaceuticals Limited 3.78% 209.303 Cr
Vijaya Diagnostic Centre Limited 3.49% 193.244 Cr
Narayana Hrudayalaya Limited 3.42% 189.190 Cr
Zydus Lifesciences Limited 3.31% 183.584 Cr
Sanofi India Limited 3.22% 178.427 Cr
Abbott India Limited 3.09% 171.218 Cr
Mankind Pharma Limited 3.08% 170.810 Cr
Ajanta Pharma Limited 3.08% 170.716 Cr
Alkem Laboratories Limited 2.70% 149.772 Cr
Torrent Pharmaceuticals Limited 2.10% 116.102 Cr
Pfizer Limited 2.08% 115.376 Cr
Fortis Healthcare Limited 2.04% 113.033 Cr
Thyrocare Technologies Limited 1.75% 96.998 Cr
Indoco Remedies Limited 1.05% 58.314 Cr
Concord Biotech Limited 1.04% 57.569 Cr
Syngene International Limited 0.86% 47.761 Cr
Orchid Pharma Limited 0.85% 46.965 Cr
GlaxoSmithKline Pharmaceuticals Limited 0.67% 36.852 Cr
Jubilant Pharmova Limited 0.37% 20.613 Cr
Healthcare Global Enterprises Limited 0.27% 14.834 Cr
Tarsons Products Limited 0.19% 10.422 Cr
Holdings % Weight Value Sahi Hai/Nahi
Triparty Repo 4.04% 224.009 Cr -
Cash Margin - CCIL 0.02% 1.263 Cr -
Net Current Assets -0.15% -8.228 Cr -

Insight on the composition of the Nippon India Pharma Fund - Growth Plan - Growth Option Fund Growth

Nippon India Pharma Fund - Growth Plan - Growth Option

Style Box of the Nippon India Pharma Fund - Growth Plan - Growth Option Fund Growth

Nippon India Pharma Fund - Growth Plan - Growth Option

Portfolio Characteristics of the Nippon India Pharma Fund - Growth Plan - Growth Option Fund Growth

Nippon India Pharma Fund - Growth Plan - Growth Option